First human test for potential future bowel disease drug begins
NCT ID NCT07281703
Summary
This is a very early study to check the safety of a new drug called HY8931 and see how the body processes it. It will involve 60 healthy adults who will receive either the drug or a placebo (a dummy treatment) as a single injection or several injections over time. The main goal is to learn if the drug is safe and well-tolerated, not to treat any condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Q-Pharm Pty Ltd.
RECRUITINGBrisbane, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.